A randomized control trial to assess the efficacy and safety of ivermectin in the treatment of mild to moderate COVID 19 patients

Authors
Category Primary study
Registry of TrialsSLCTR
Year 2021
This article has no abstract
Epistemonikos ID: 18bd8ec47e9348cb5c7dcec2065ad19c361161d5
First added on: Oct 08, 2021